Inframammary, intertriginous, and decubital erosions due to etretinate.
Puzzling, treatment-resistant oval erosions occurred in a forty-two-year-old woman shortly after treatment with etretinate was begun for psoriasis. Appearing on the breasts, inguinal folds, and buttocks, these lesions persisted and increased in size and number during three months of hospitalization. The cause proved to be etretinate; stopping use of the drug led to complete healing within three weeks.
Shelley
E D
ED
Department of Medicine, Medical College of Ohio, Toledo 43699.
Shelley
W B
WB
D000328:Adult; D001941:Breast Diseases / Q000209:etiology*; D002081:Buttocks; D003875:Drug Eruptions / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005050:Etretinate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010388:Pelvis; D011565:Psoriasis / Q000188:drug therapy
D005050:Etretinate